Skip to Main Content

Paper Details

Safety of Dueling NSCLC With Dual Agent Immunotherapy.
J Thorac Oncol
0
2023
Author NameAffiliation
Thomas JohnPeter MacCallum Cancer Centre, The University of Melbourne
  • 1 - 1

Datasets

Release 1.2